ECG

ECG R&D to Revenue

0.00%Fiscal year

Period ending:

ECG FY R&D/Revenue%
ECG FY R&D/Revenue1.00%-1.00%
2021-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

ECG r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 5 observations from Dec 31, 2021 to Dec 31, 2025.

Everus Construction Group, Inc. Common Stock R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
0%
0%
0%
0%
0%

Compare r&d to revenue

All ECG financial metrics · ECG stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.